Oncology & Cancer

Germany's BioNTech plans UK trial of mRNA cancer therapy

German pharmaceutical company BioNTech, which developed a trailblazing COVID-19 vaccine, will trial a cancer treatment in Britain using the same mRNA technology, the company said on Friday.

Medical research

Expanding the arsenal of drugs for use against COVID-19

The ongoing COVID-19 pandemic, caused by the SARS-CoV-2 virus, has been devastating the entire world. While the vaccination program is advancing, drug treatments for COVID-19 are still highly important for those who become ...

Medications

Countering pharma's expensive gaming of the drug patent system

Biomedical innovation reached a new era during the COVID-19 pandemic as drug development went into overdrive. But the ways that brand companies license their patented drugs grant them market monopoly, preventing other entities ...

Psychology & Psychiatry

Exploring the consequences of early life adversity on the brain

Using cutting edge molecular techniques in rodent models, researchers are dissecting the neurobiological mechanisms impacted by early life adversity. The findings were presented at Neuroscience 2022, the annual meeting of ...

page 14 from 40